Table 1.
The most significant GO biofunction and KEGG pathways in the enrichment analysis.
Class | Function/pathway | p value | p. adjust | q-value |
---|---|---|---|---|
BP | Response to hypoxia | 7.92E-09 | 3.08E-05 | 2.57E-05 |
Response to decreased oxygen levels | 1.50E-08 | 3.08E-05 | 2.57E-05 | |
Response to oxygen levels | 5.54E-08 | 7.58E-05 | 6.32E-05 | |
Reproductive structure development | 9.59E-08 | 9.10E-05 | 7.58E-05 | |
Reproductive system development | 1.11E-07 | 9.10E-05 | 7.58E-05 | |
Pattern specification process | 6.59E-07 | 0.000450942 | 0.00037565 | |
Urogenital system development | 1.52E-06 | 0.000852121 | 0.000709846 | |
Axonogenesis | 1.66E-06 | 0.000852121 | 0.000709846 | |
Response to glucocorticoid | 2.04E-06 | 0.000874411 | 0.000728415 | |
Acute inflammatory response | 2.34E-06 | 0.000874411 | 0.000728415 | |
KEGG | PI3K-Akt signalling pathway | 3.00E-05 | 0.007825176 | 0.007132445 |
PPAR signalling pathway | 7.00E-05 | 0.009139327 | 0.00833026 | |
MAPK signalling pathway | 0.000198423 | 0.014943102 | 0.01362025 | |
Oocyte meiosis | 0.000229013 | 0.014943102 | 0.01362025 |